featured
Extended Genetic Profiling to Predict Benefit of Lenalidomide Maintenance in Patients With Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Optimizing the value of lenalidomide maintenance by extended genetic profiling: an analysis of 556 patients in the Myeloma XI trial
Blood 2023 Apr 06;141(14)1666-1674, A Panopoulou, DA Cairns, A Holroyd, I Nichols, N Cray, C Pawlyn, G Cook, M Drayson, K Boyd, FE Davies, M Jenner, GJ Morgan, R Owen, R Houlston, G Jackson, MF KaiserFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.